Grant: Operating Grant
McMaster University
$608,015.00
Investigating the Role of Glycogen Synthase Kinase (GSK)-3 in Accelerated Atherogenesis
FY 2013-14
Summary
Heart attacks and strokes are responsible for more deaths in Canada than any other disease. It is known that a condition called atherosclerosis (the thickening of the blood vessel walls) is the underlying cause of most heart attacks and strokes. It is also known that certain risk factors, including smoking, obesity, high blood cholesterol, diabetes, and high blood pressure, promote the development of atherosclerosis. However, it is not known how or why this occurs. If we know why, we can design ways to slow, stop or reverse disease progression.
We have found a new pathway that might be an important link between cardiovascular risk factors and atherosclerosis. The objective of this study is to determine the role of this pathway in disease development and progression. The pathway that we have found involves a particular kind of stress (called ER stress). We believe that, when this stress is present, a factor (a protein) called GSK3 is activated. We have evidence that activated GSK3 can turn on other factors that can lead to the development of atherosclerosis.
We have established a unique collection of cells and animal model systems that will allow us to investigate the links between risk factors - like diabetes - and the development of atherosclerosis. We are working in a step by step fashion to determine how risk factors cause ER stress, how ER stress activates GSK3 and how GSK3 is involved in atherosclerosis. In the course of these studies we hope to find ways in which this whole process can be blocked. In this way, our research could lead to the development of new effective treatments for cardiovascular disease
Department
Program
Operating Grant
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
290635
Name
Werstuck Geoffrey H
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Circulatory and Respiratory Health
Theme2
Biomedical
Prcname2
Cardiovascular System - C: Vascular System
Projecttitle
Investigating the Role of Glycogen Synthase Kinase (GSK)-3 in Accelerated Atherogenesis
Programtype2
Operating Grants
Orgnameinp2
McMaster University
Cihramount2
$608,015
Cihrequipment2
$0
Programname2
Operating Grant
Keyworddelim
Animal Models; Atherosclerosis; Endoplasmic Reticulum (Er) Stress; Glycogen Synthase Kinase (Gsk)-3; Molecular Mechanisms
Abstract
Heart attacks and strokes are responsible for more deaths in Canada than any other disease. It is known that a condition called atherosclerosis (the thickening of the blood vessel walls) is the underlying cause of most heart attacks and strokes. It is also known that certain risk factors, including smoking, obesity, high blood cholesterol, diabetes, and high blood pressure, promote the development of atherosclerosis. However, it is not known how or why this occurs. If we know why, we can design ways to slow, stop or reverse disease progression.
We have found a new pathway that might be an important link between cardiovascular risk factors and atherosclerosis. The objective of this study is to determine the role of this pathway in disease development and progression. The pathway that we have found involves a particular kind of stress (called ER stress). We believe that, when this stress is present, a factor (a protein) called GSK3 is activated. We have evidence that activated GSK3 can turn on other factors that can lead to the development of atherosclerosis.
We have established a unique collection of cells and animal model systems that will allow us to investigate the links between risk factors - like diabetes - and the development of atherosclerosis. We are working in a step by step fashion to determine how risk factors cause ER stress, how ER stress activates GSK3 and how GSK3 is involved in atherosclerosis. In the course of these studies we hope to find ways in which this whole process can be blocked. In this way, our research could lead to the development of new effective treatments for cardiovascular disease
Competitiondate
201309
Approvedterm2
5 yrs 0 mth
Pinamesdelim
Werstuck, Geoffrey H
Approvedterm
5 ans 0 mois
Cihrcontribution2
~ $608,015~ $0~